Thermo Fisher Scientific (TMO) Financials

$671.50

$-6.89 (-1.02%)

As on 25-Sep-2026 13:43EDT

Market cap

$243,412 Mln

Revenue (TTM)

$46,336 Mln

P/E Ratio

34.9

P/B Ratio

4.6

Div. Yield

0.3 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	46,336.00	44,556.00	42,879.00	42,857.00	44,915.00	39,211.00
Cost of Revenue	27,629.00	27,778.00	25,151.00	25,295.00	25,904.00	19,577.00
Gross Profit	18,707.00	16,778.00	17,728.00	17,562.00	19,011.00	19,634.00
Operating Expenses	10,515.00	8,669.00	10,066.00	10,703.00	10,486.00	9,316.00
Operating Profit (EBIT)	8,195.00	8,109.00	7,662.00	6,859.00	8,525.00	10,318.00
Other Income	--	--	--	--	-4.00	-655.00
Profit before Tax	7,609.00	7,267.00	6,995.00	6,298.00	7,663.00	8,837.00
Provision for Tax	597.00	547.00	657.00	-284.00	703.00	1,109.00
Profit after Tax (Net Income)	6,978.00	6,737.00	6,335.00	5,995.00	6,950.00	7,725.00
Minority Interest	-21.00	-17.00	-3.00	18.00	-10.00	-3.00
Consolidated Profit	3,580.00	6,704.00	6,335.00	5,995.00	6,950.00	7,725.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	52,679.00	53,407.00	49,584.00	46,735.00	43,978.00	40,793.00
Minority Interest	-21.00	--	--	--	54.00	62.00
Non-Current Liabilities	45,298.00	41,618.00	34,318.00	37,872.00	35,996.00	40,710.00
Current Liabilities	15,069.00	15,189.00	13,332.00	14,012.00	17,010.00	13,436.00
Total Liabilities	128,243.00	110,343.00	97,321.00	98,726.00	97,154.00	95,123.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	89,809.00	81,636.00	75,184.00	74,137.00	71,925.00	75,010.00
Current Assets	23,365.00	28,707.00	22,137.00	24,589.00	25,229.00	20,113.00
Total Assets	128,243.00	110,343.00	97,321.00	98,726.00	97,154.00	95,123.00
Total Debt*	42,549.00	39,385.00	32,775.00	36,424.00	36,073.00	36,339.00
Net Current Assets	8,296.00	13,518.00	8,805.00	10,577.00	8,251.00	6,726.00

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	7,818.00	8,667.00	8,406.00	9,154.00	9,543.00
Cash Flow from Investing Activities	--	-4,047.00	-5,841.00	-5,142.00	-2,159.00	-21,932.00
Cash from Financing Activities	--	1,801.00	-6,792.00	-3,622.00	-2,810.00	6,581.00
Net Cash Inflow / Outflow	--	--	--	--	4,185.00	-6,039.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	18.62	17.87	16.54	15.45	17.68	19.41
Cash EPS ($)	--	25.24	24.66	24.25	26.29	25.92
Adjusted Book Value ($)	--	141.66	129.46	120.45	111.90	102.49
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	20.74	22.63	21.66	23.29	23.98
Free Cash Flow per Share ($)	--	16.69	18.97	17.85	17.59	17.64

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	7.69	7.65	7.35	8.84	11.51
ROE (%)	13.12	13.08	13.15	13.22	16.40	20.52
ROA (%)	5.76	6.49	6.46	6.12	7.23	9.41
EBIT Margin (%)	18.62	19.49	20.27	16.00	19.06	23.91
Net Margin (%)	15.06	15.12	14.77	13.99	15.48	20.04
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	7.23	0.04	0.00	-0.05	0.15	0.22
EBIT Growth (%)	1.20	-0.07	26.72	-19.88	-8.70	20.48
Net Profit Growth (%)	5.67	6.35	5.67	-13.74	-10.03	21.18
EPS Growth (%)	7.77	0.08	0.07	-0.13	-0.09	0.22
Book Value Growth (%)	6.26	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	34.85	32.43	31.45	34.35	31.14	34.38
Price / Book Value	4.55	4.09	4.02	4.41	4.92	6.51
Dividend Yield (%)	0.28	--	--	--	--	--
EV/EBITDA	23.10	21.61	19.19	34.44	20.43	24.85
Close Price ($)	501.36	579.45	520.23	530.79	550.69	667.24
High Price ($)	643.99	610.97	627.88	609.85	672.34	672.34
Low Price ($)	403.36	385.46	493.30	415.60	475.77	433.52
Market Cap ($ Cr)	243,412.04	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	0.74	0.74	0.66	0.78	0.82	0.89
Short term debt to equity ratio	0.06	0.07	0.05	0.08	0.13	0.07
Current Ratio	1.55	1.89	1.66	1.75	1.48	1.50
Quick Ratio	1.18	1.53	1.29	1.39	1.15	1.12
Interest Coverage	6.19	6.12	5.26	4.99	11.79	17.49

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	20.40	23.71	22.45	22.55	20.99	22.81
Asset Turnover	0.38	0.43	0.44	0.44	0.47	0.48
Receivable days	--	82.76	82.16	81.35	74.70	71.80
Inventory Days	--	68.39	73.09	77.41	75.33	84.70
Payable days	--	44.06	43.21	45.15	44.05	47.03
Cash Conversion Cycle	--	107.10	112.04	113.62	105.98	109.47

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)